Personalis Inc (PSNL)

Feb 20, 2026

How Personalis Inc. stock performs in weak economyJuly 2025 Macro Moves & Entry Point Confirmation Alerts - mfd.ru

Feb 20, 2026

Feb 20, 2026

Personalis (NASDAQ:PSNL) Shares Down 4.8%Should You Sell? - MarketBeat

Feb 20, 2026

Feb 19, 2026

Aberdeen Group plc Increases Stock Position in Personalis, Inc. $PSNL - MarketBeat

Feb 19, 2026

Feb 19, 2026

Personalis (PSNL) to Release Earnings on Thursday - MarketBeat

Feb 19, 2026

Feb 18, 2026

Personalis to Participate in the TD Cowen 46th Annual Healthcare Conference - BioSpace

Feb 18, 2026

Feb 17, 2026

Personalis (NASDAQ:PSNL) Trading Up 6.2%Time to Buy? - MarketBeat

Feb 17, 2026

Feb 17, 2026

Personalis, Inc. (PSNL) ctDNA Test Predicts TNBC Relapse Risk Post-Therapy - MSN

Feb 17, 2026

Feb 15, 2026

Why Personalis Inc. stock could benefit from AI revolutionJuly 2025 Movers & Low Risk Growth Stock Ideas - mfd.ru

Feb 15, 2026

Feb 14, 2026

Personalis gains as VA awards work order worth up to $13.5M - MSN

Feb 14, 2026

Feb 14, 2026

Personalis, Inc. (NASDAQ:PSNL) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Feb 14, 2026

Feb 13, 2026

Aug Mood: Is Personalis Inc showing insider buyingTrade Entry Report & Real-Time Price Movement Reports - baoquankhu1.vn

Feb 13, 2026

Feb 13, 2026

Personalis, Inc. (PSNL) Stock Analysis: Evaluating a 34.51% Upside Potential in the Diagnostics Sector - DirectorsTalk Interviews

Feb 13, 2026

Feb 13, 2026

Aug Patterns: Will Personalis Inc outperform small cap indexesJuly 2025 Volume & Capital Protection Trade Alerts - baoquankhu1.vn

Feb 13, 2026

Feb 12, 2026

Personalis to Announce Fourth Quarter and Full Year 2025 Financial Results - BioSpace

Feb 12, 2026

Feb 12, 2026

Why Personalis Stock Is Rising: Medicare Covers Luncg Cancer MRD Test - MSN

Feb 12, 2026

Feb 12, 2026

Personalis Data Breach Lawsuit Investigation - Claim Depot

Feb 12, 2026

Feb 12, 2026

Medicare Now Covers NeXT Personal® MRD Testing for Lung Cancer SurveillancePersonalis, Inc. - Oncodaily

Feb 12, 2026

Feb 12, 2026

Personalis (NASDAQ:PSNL) Price Target Raised to $13.00 - MarketBeat

Feb 12, 2026

Feb 11, 2026

Will Personalis Inc. outperform small cap indexesJuly 2025 Big Picture & High Conviction Investment Ideas - mfd.ru

Feb 11, 2026

Feb 11, 2026

Medicare approves Personalis’ lung cancer test for surveillance By Investing.com - Investing.com Australia

Feb 11, 2026

Feb 11, 2026

Biotech operator Personalis sees 10% spike from Medicare covering lung cancer blood test - Mugglehead Investment Magazine

Feb 11, 2026

Feb 10, 2026

Personalis (PSNL) Gains 10% Following Medicare Coverage for Canc - GuruFocus

Feb 10, 2026

Feb 10, 2026

Medicare approves Personalis’ lung cancer test for surveillance - Investing.com Nigeria

Feb 10, 2026

Feb 10, 2026

Personalis stock rises after Medicare approves lung cancer test coverage - Investing.com South Africa

Feb 10, 2026

Feb 10, 2026

Personalis (NASDAQ:PSNL) Shares Gap UpShould You Buy? - MarketBeat

Feb 10, 2026

Feb 10, 2026

Personalis stock rises after Medicare approves lung cancer test coverage By Investing.com - Investing.com Australia

Feb 10, 2026

Feb 10, 2026

Personalis wins Medicare coverage for NeXT Personal (PSNL) - Seeking Alpha

Feb 10, 2026

Feb 10, 2026

Why Is Personalis Stock Soaring Tuesday?Personalis (NASDAQ:PSNL) - Benzinga

Feb 10, 2026

Feb 10, 2026

Why Personalis Stock Is Rising: Medicare Covers Lung Cancer MRD Test - Asianet Newsable

Feb 10, 2026

Feb 10, 2026

Personalis rises as Medicare extends coverage to lung cancer test - TradingView

Feb 10, 2026

Feb 10, 2026

Personalis Inc receives Medicare coverage for Next Personal in lung cancer surveillance - marketscreener.com

Feb 10, 2026

Feb 10, 2026

Personalis Receives Medicare Coverage for NeXT Personal® in Lung Cancer Surveillance - Business Wire

Feb 10, 2026

Feb 10, 2026

Personalis Inc Receives Medicare Coverage For Next Personal In Lung Cancer Surveillance - TradingView

Feb 10, 2026

Feb 09, 2026

Revenue Check: Can Personalis Inc stock double in the next yearJuly 2025 Reactions & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn

Feb 09, 2026

Feb 07, 2026

Wellington Shields Capital Management LLC Cuts Stake in Personalis, Inc. $PSNL - MarketBeat

Feb 07, 2026

Feb 06, 2026

Breakthrough Cancer Monitoring Technique Fuels Growth for Personalis - AD HOC NEWS

Feb 06, 2026

Feb 04, 2026

Aug Final Week: Is Personalis Inc showing insider buyingLong Setup & AI Enhanced Trading Signals - baoquankhu1.vn

Feb 04, 2026

Feb 02, 2026

Personalis, Inc. (PSNL): A Bull Case Theory - Yahoo Finance

Feb 02, 2026

Feb 02, 2026

Personalis (PSNL) Study Highlights NeXT Personal's Impact in Can - GuruFocus

Feb 02, 2026

Feb 02, 2026

Personalis Announces New Publication Expanding Evidence for Ultrasensitive ctDNA Monitoring of Cancer Immunotherapy Response Across Solid Tumors - Business Wire

Feb 02, 2026

Jan 31, 2026

Personalis, Inc. (PSNL) Stock Analysis: A 11.76% Potential Upside Amidst Revenue Challenges - DirectorsTalk Interviews

Jan 31, 2026

Jan 31, 2026

Wall Street Zen Upgrades Personalis (NASDAQ:PSNL) to Hold - MarketBeat

Jan 31, 2026

Jan 29, 2026

Is Personalis Inc.’s growth already priced inJuly 2025 Recap & Consistent Return Strategy Ideas - mfd.ru

Jan 29, 2026

Jan 29, 2026

Personalis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - BioSpace

Jan 29, 2026

Jan 26, 2026

Insider Selling: Personalis (NASDAQ:PSNL) CFO Sells $13,811.50 in Stock - Defense World

Jan 26, 2026

Jan 26, 2026

What 9 Analyst Ratings Have To Say About Personalis - Benzinga

Jan 26, 2026

Jan 26, 2026

Guggenheim Raises Price Target for Personalis (PSNL) to $13.00 | PSNL Stock News - GuruFocus

Jan 26, 2026